close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar18Point50
Implied share price

Sell Overvalued by 22.0%

5% margin of safety What's this?

EV / EBITDA
Use Average
BSX
Boston Scientific Corporation
MDT
Medtronic, Inc.
Change
ACL
Alcon, Inc.
Change
COV
Covidien Ltd.
Change
SYK
Stryker Corporation
Change
16.81 20.73 15.65 17.39 19.42 16.38
All amounts in millions
from last financial year
         
Implied Share Price $18.50 $93.75 $162.69 $92.55 $119.52
Market Cap 32,290 119,344 50,798 49,118 43,583
Net Debt 5,358 18,606 -3,015 3,477 -81
Enterprise Value (EV) 37,648 137,949 47,783 52,595 43,467
Revenue 7,477 28,833 7,179 10,659 9,946
EBITDA 1,816 8,813 2,747 2,709 2,654
Percent 24.3 % 30.6 % 38.3 % 25.4 % 26.7 %
EBIT 1,047 5,993 2,475 2,129 2,257
Percent 14.0 % 20.8 % 34.5 % 20.0 % 22.7 %
Balance Sheet          
Total Assets 18,133 99,782 10,073 20,701 16,223
Total Liabilities 11,813 47,719 2,821 10,641 7,712
Shareholders Equity 6,320 52,063 7,252 10,060 8,511.0

Price history

Comments

No comments yet. Login to comment.